RESUMO
We describe a 2-year-old girl with recurrent giant cell fibroblastoma (GCF) of the postsacrococcygeal region. Both the initial and recurrent tumours contained solid and angiectoid areas. The former was composed of loosely arranged wavy spindle cells and giant cells with a well-vascularized myxoid to collagenous stroma. The angiectoid spaces were often lined by multinucleated giant cells. Immunohistochemically, the tumour cells and small vessels in the tumour tissue were positive for platelet-derived growth factor (PDGF) alpha and beta receptors. Molecular analysis revealed fusion of collagen type Ialpha1 exon 26 with PDGF-B chain exon 2 that induced unscheduled production of PDGF-BB. These findings suggest that PDGF and its receptors significantly contribute to the development of GCF in both an autocrine and a paracrine manner.
Assuntos
Dermatofibrossarcoma/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas de Fusão Oncogênica/metabolismo , Receptores do Fator de Crescimento Derivado de Plaquetas/metabolismo , Neoplasias Cutâneas/metabolismo , Sequência de Bases , Dermatofibrossarcoma/patologia , Dermatofibrossarcoma/cirurgia , Feminino , Humanos , Lactente , Dados de Sequência Molecular , Proteínas de Neoplasias/genética , Recidiva Local de Neoplasia/metabolismo , Proteínas de Fusão Oncogênica/genética , Receptor alfa de Fator de Crescimento Derivado de Plaquetas/metabolismo , Receptor beta de Fator de Crescimento Derivado de Plaquetas/metabolismo , Região Sacrococcígea , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgiaRESUMO
Glioblastomas are the most common primary brain tumors in adults. These tumors exhibit a high degree of vascularization, and malignant progression from astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation of vascular endothelial growth factor and its receptors. In this study, we investigated the in vivo antiangiogenic and antitumor effects of brain-specific angiogenesis inhibitor 1 (BAI1) using human glioblastoma cell lines. Glioblastoma cells were transduced with an adenoviral vector encoding BAI1 (AdBAI1), and Northern and Western blot analyses, respectively, demonstrated BAI1 mRNA and protein expression in the transduced tumor cells. Using an in vivo neovascularization assay, we found that angiogenesis surrounding AdBAI1-transduced glioblastoma cells transplanted into transparent skinfold chambers of SCID mice was significantly impaired compared to control treated cells. Additionally, in vivo inoculation with AdBAI1 of established subcutaneous or intracerebral transplanted tumors significantly impaired tumor growth and promoted increased mouse survival. Morphologically, the tumors exhibited signs of impaired angiogenesis, such as extensive necrosis and reduced intratumoral vascular density. Taken together, these data strongly indicate that BAI1 may be an excellent gene therapy candidate for the treatment of brain tumors, especially human glioblastomas.
Assuntos
Proteínas Angiogênicas/biossíntese , Neoplasias Encefálicas/irrigação sanguínea , Glioblastoma/irrigação sanguínea , Neovascularização Patológica/terapia , Adenoviridae/genética , Proteínas Angiogênicas/genética , Animais , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/terapia , Linhagem Celular Tumoral , Terapia Genética , Vetores Genéticos , Glioblastoma/patologia , Glioblastoma/terapia , Humanos , Camundongos , Camundongos SCID , Transplante de Neoplasias , RNA Mensageiro/metabolismo , Receptores Acoplados a Proteínas G , Transdução GenéticaRESUMO
We report a 75-year-old Japanese woman with classic Kaposi's sarcoma. PCR amplified human herpesvirus 8 (HHV-8) DNA sequences from her skin lesions and peripheral blood mononuclear cells (PBMC), but not her plasma, saliva or urine. An antibody test against HHV-8 lytic antigens was positive. Immunohistochemical staining detected latent antigen. There was no evidence of HHV-8 infection in her husband, sister or daughter. Genes coding for HHV-8-encoded viral interleukin-6, viral macrophage inflammatory protein I, viral G protein-coupled receptor, viral cyclin D and viral Bcl-2 were expressed to the same degree in both her skin lesion and PBMC. Latency-associated T0.7 mRNA and HHV-8-encoded viral tegument protein genes were expressed in her PBMC at levels lower than in the skin lesions. Based on the gene expression profile, we concluded that lytic HHV-8 infection was present in her skin lesions and PBMC.
Assuntos
Herpesvirus Humano 8/genética , Leucócitos Mononucleares/virologia , Sarcoma de Kaposi/virologia , Neoplasias Cutâneas/virologia , Idoso , Antígenos Virais/análise , DNA Viral/análise , Saúde da Família , Feminino , Soronegatividade para HIV , Humanos , Imuno-Histoquímica , Sarcoma de Kaposi/imunologia , Transcrição Gênica/genéticaRESUMO
We describe a 72-year-old man with mycosis fungoides (MF) followed up at our hospital for more than 20 years, who has developed 14 eccrine poromas (EPs) in the past 12 years. Twelve of these tumours were ascertained as EP histopathologically without any findings of malignancy and the other two were clinically diagnosed and are not yet resected. To our knowledge, this is the first case report of MF complicated with multiple EPs. In our patient, all EPs arose in skin areas previously irradiated with an electron beam for the treatment of MF, suggesting that electron beam irradiation might have an effect on the development of EPs.
Assuntos
Acrospiroma/etiologia , Micose Fungoide/radioterapia , Neoplasias Induzidas por Radiação/etiologia , Segunda Neoplasia Primária/etiologia , Neoplasias das Glândulas Sudoríparas/etiologia , Idoso , Seguimentos , Humanos , Masculino , Neoplasias Cutâneas/radioterapiaRESUMO
We report a 70-year-old patient with sarcoidosis associated with psoriasis vulgaris. He had a nodule on the medial lower lid of his right eye. Oral corticosteroid for the sarcoid lesions and oral PUVA for psoriasis were employed. The cutaneous lesion disappeared within two months after starting the therapy. No relapse of sarcoidosis has been seen for eight years. The association of sarcoidosis with psoriasis has been previously reported; however, it is still unclear whether this association coincidental or meaningful.
Assuntos
Granuloma de Células Gigantes/diagnóstico , Psoríase/diagnóstico , Sarcoidose Pulmonar/diagnóstico , Idoso , Diagnóstico Diferencial , Pálpebras , Glucocorticoides/uso terapêutico , Granuloma de Células Gigantes/complicações , Granuloma de Células Gigantes/tratamento farmacológico , Granuloma de Células Gigantes/patologia , Humanos , Masculino , Terapia PUVA , Prednisolona/uso terapêutico , Psoríase/complicações , Psoríase/tratamento farmacológico , Psoríase/patologia , Sarcoidose Pulmonar/complicações , Sarcoidose Pulmonar/tratamento farmacológico , Sarcoidose Pulmonar/patologia , Dermatopatias/complicações , Dermatopatias/diagnóstico , Dermatopatias/tratamento farmacológico , Dermatopatias/patologiaRESUMO
Surgical medicine has developed with contribution from the basic medical sciences. At the same time, the life sciences have developed rapidly and are being applied clinically. Thus, the 20th century was the "age of science," and the age when science was valued the most. What is necessary in the 21st century? The further development of surgery is anticipated. In addition, since it is believed that the 21st century will be the "age of the individual". I think that surgical medicine should address human individuality. In the 21st century, the Japan Surgical Society should promote surgical medicine by adhering to the dictum of Ambroise Pare: "to cure sometimes, to relieve often, to comfort always."
Assuntos
Cirurgia Geral/tendências , Individualidade , Atitude do Pessoal de Saúde , Educação Médica , Cirurgia Geral/educaçãoRESUMO
Patent blue is a dye that has been used for intraoperative lymphatic mapping. We used this mapping method on a patient with lymphorrhea after groin dissection. We easily detected the lymphatic channel causing lymphorrhea and successfully ligated it. This technique may have great merit for treating of lymphorrhea.
Assuntos
Corantes , Excisão de Linfonodo/efeitos adversos , Linfedema/diagnóstico , Linfedema/etiologia , Melanoma/cirurgia , Neoplasias Cutâneas/cirurgia , Seguimentos , Humanos , Excisão de Linfonodo/métodos , Linfedema/cirurgia , Masculino , Melanoma/diagnóstico , Pessoa de Meia-Idade , Monitorização Intraoperatória/métodos , Neoplasias Cutâneas/diagnósticoRESUMO
Sarcoidosis is a systemic granulomatous disorder which commonly affects the skin. Involvement of the tongue is rare; a review of the previous literature over the last 30 years revealed only six cases of sarcoidosis affecting the tongue. We studied a case of sarcoidosis involving the tongue in a 32-year-old Japanese woman with characteristic clinical and pathological findings. She visited our department with a complaint of a tongue lesion of which she had been aware for a month. A diagnosis of sarcoidosis was made for the lesion by clinical and pathological examinations. Oral involvement by sarcoidosis is rare, however this disorder should be considered as a possible cause of intraoral granulomatous lesions.
Assuntos
Sarcoidose/diagnóstico , Doenças da Língua/diagnóstico , Corticosteroides/administração & dosagem , Adulto , Feminino , Humanos , Injeções Intralesionais , Sarcoidose/tratamento farmacológico , Sarcoidose/patologia , Tomografia Computadorizada por Raios X , Doenças da Língua/tratamento farmacológico , Doenças da Língua/patologia , Resultado do TratamentoRESUMO
We describe two female patients with gigantic dystrophic calcinosis cutis caused by a large number of subcutaneous and/or intramuscular injections which they received when they were much younger. Laboratory data and physical examinations were generally within normal limits, and we detected no disease which might induce cutaneous calcification. There are many reports of dystrophic calcinosis cutis caused by injection of several kinds of drugs. However, we found no previous report describing a patient with calcinosis cutis induced by local tissue injury from a large number of injections and with extraordinarily widespread calcification at the injection sites. Because we do not know the exact drugs injected, it is difficult to say if a specific ingredient in the injections was related to this condition. We do know that a large number of subcutaneous or intramuscular injections were frequently administered to patients who had difficulty in maintaining venous infusions in the past, so there may be similar cases of dystrophic calcinosis cutis which have not been reported.
Assuntos
Calcinose/etiologia , Calcinose/patologia , Injeções Intramusculares/efeitos adversos , Injeções Subcutâneas/efeitos adversos , Dermatopatias/etiologia , Dermatopatias/patologia , Idoso , Biópsia por Agulha , Calcinose/cirurgia , Cálcio/metabolismo , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Dermatopatias/cirurgia , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
A nerve growth factor receptor encoded by the TRKA gene plays an important part in the formation of autonomic neurons and small sensory neurons in dorsal root ganglia and in signal transduction through its intracytoplasmic tyrosine kinase domain. Recently, three mutations in the tyrosine kinase domain of TRKA have been reported in patients with congenital insensitivity to pain with anhidrosis, which is an autosomal recessive disorder characterized by recurrent fever due to absence of sweating, no reaction to noxious stimuli, self-mutilating behavior, and mental retardation. We examined the TRKA gene in five generations of a large Japanese family with many consanguineous marriages who live in a small remote island of the southern part of Japan. We found a novel point mutation at nucleotide 1825 (A-->G transition) resulting in Met-581-Val in the tyrosine kinase domain. Two of the three affected patients were homozygous for this mutation; however, the third affected patient was heterozygous. Further analysis revealed that the third patient was a compound heterozygote with the Met-581-Val mutation in one allele and with a single base C deletion mutation at nucleotide 1726 in exon 14 in the other allele, resulting in a frameshift and premature termination codon.
Assuntos
Hipo-Hidrose/complicações , Hipo-Hidrose/genética , Insensibilidade Congênita à Dor/complicações , Insensibilidade Congênita à Dor/genética , Mutação Puntual , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Receptores Proteína Tirosina Quinases/genética , Receptores de Fator de Crescimento Neural/genética , Adulto , Análise Mutacional de DNA , Éxons/genética , Feminino , Genes Recessivos , Triagem de Portadores Genéticos , Heterozigoto , Homozigoto , Humanos , Masculino , Pessoa de Meia-Idade , Linhagem , Receptor trkARESUMO
Human T-cell lymphotropic virus type I (HTLV-I) is known to be associated with several non-neoplastic inflammatory disorders such as HTLV-I-associated myelopathy/tropical spastic paraparesis, arthropathy, uveitis and lymphadenitis, in addition to neoplastic adult T-cell leukemia/lymphoma (ATLL). A strong relation between HTLV-I infection and Sjögren's syndrome (SS) has been reported, and impaired sweating in SS is well known. We have often encountered dry skin in patients with ATLL. On the basis of these observations, we aimed to determine whether HTLV-I infection is present in isolated sweat glands. Eccrine gland epithelia were isolated from full thickness skin biopsies from 8 HTLV-I-seropositive and 7 seronegative individuals using dispase in Eagle's minimum essential medium supplemented with 13% fetal calf serum. We detected HTLV-IpX sequences in samples of eccrine sweat gland epithelia from 4 samples of the 8 seropositive individuals using nested polymerase chain reaction, but all 7 samples from the seronegative donors had no signal corresponding to the sequence. Our results were confirmed by dot blot hybridization. Our results suggest that eccrine epithelium is one of the target organs of HTLV-I infection.
Assuntos
Glândulas Écrinas/virologia , Vírus Linfotrópico T Tipo 1 Humano/isolamento & purificação , Leucemia-Linfoma de Células T do Adulto/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/virologia , DNA Viral/isolamento & purificação , Glândulas Écrinas/patologia , Células Epiteliais/patologia , Células Epiteliais/virologia , Feminino , Humanos , Leucemia-Linfoma de Células T do Adulto/virologia , Lúpus Eritematoso Sistêmico/patologia , Lúpus Eritematoso Sistêmico/virologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Úlcera Cutânea/patologia , Úlcera Cutânea/virologiaRESUMO
Chromosome translocations involving band 12p13 are known to be involved in a variety of hematologic malignancies, some of them resulting in rearrangement of the ETV6/TEL gene. Applying the fluorescence in situ hybridization (FISH) method, we found a cryptic translocation t(12;15)(p13;q25) in an adult acute myeloid leukemia (AML) patient. Hybridization with cosmid probes showed that the ETV6 gene was rearranged in this translocation. A patient-specific cDNA library was screened with ETV6 cDNA, and a novel fusion transcript was identified between the ETV6 and TRKC/NTRK3 gene located on 15q25. TRKC is a receptor tyrosine kinase that is activated by neurotrophin-3 (NT-3). It is known to be expressed broadly in neural tissues but not in hematologic cells, so far. ETV6-TRKC chimeric transcript encoded the pointed (PNT) domain of the ETV6 gene that fused to the protein-tyrosine kinase (PTK) domain of the TRKC gene. Two types of fusion transcript were determined, one that included the entire PTK domain of TRKC and the other in which the 3'-terminal 462 bp of TRKC was truncated within the PTK domain. Western blot analysis showed the expression of both chimeric proteins of 52 and 38 kD in size. Our results suggest that chimeric PTK expressed in the leukemic cells may contribute to cellular transformation by abnormally activating TRK signaling pathways. Moreover, this is the first report on truncated neurotrophin receptors associated in leukemia.
Assuntos
Cromossomos Humanos Par 12 , Cromossomos Humanos Par 15 , Proteínas de Ligação a DNA/genética , Leucemia Mieloide/genética , Receptores Proteína Tirosina Quinases/genética , Receptores de Fator de Crescimento Neural/genética , Proteínas Repressoras , Fatores de Transcrição/genética , Translocação Genética , Doença Aguda , Adulto , Sequência de Aminoácidos , Sequência de Bases , Mapeamento Cromossômico , Rearranjo Gênico , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Proteínas Proto-Oncogênicas c-ets , Receptor trkC , Variante 6 da Proteína do Fator de Translocação ETSRESUMO
The granulocyte colony-stimulating factor (G-CSF)-induced gene, GIG-1, was originally cloned from G-CSF-stimulated bone marrow mononuclear cells obtained from a patient with chronic myelogenous leukemia (CML). We have characterized the GIG-1 gene and its protein product. Expression of GIG-1 mRNA was elevated by treatment with G-CSF in normal bone marrow mononuclear cells, as well as in some cases of blast cells obtained from patients with acute myelogenous leukemia (AML) and CML. Western blot analysis with anti-GIG-1 peptide antiserum showed the molecular mass of GIG-1 product was about 17 kDa. Immunostaining of the hematopoietic cells demonstrated that GIG-1 product was mainly localized to the cytoplasm of both myeloid and natural killer (NK) cells. These results suggested that GIG-1 protein is an integral component that is accumulated during the differentiation of myeloid cells toward the stage of mature neutrophils. Expression of GIG-1 gene in mature neutrophils was tightly regulated and reactivation of GIG-1 gene by G-CSF in mature neutrophils may represent a compensation process for the protein lost through the activation of these cells, thus implying an important role for this protein in host defense mechanisms.
Assuntos
Células Matadoras Naturais/metabolismo , Leucemia Mielogênica Crônica BCR-ABL Positiva/metabolismo , Leucemia Mieloide Aguda/metabolismo , Proteínas de Membrana/biossíntese , Proteínas , Proteínas de Ligação a RNA/biossíntese , Antígenos CD34/sangue , Western Blotting , Células da Medula Óssea/metabolismo , Sangue Fetal/citologia , Sangue Fetal/metabolismo , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Proteínas de Membrana/genética , Proteínas de Ligação a Poli(A) , RNA Mensageiro/metabolismo , Proteínas de Ligação a RNA/genética , Antígeno-1 Intracelular de Células T , Células Tumorais CultivadasRESUMO
Adult T-cell leukemia/lymphoma (ATLL) commonly involves the skin as well as peripheral blood and lymph nodes. During the last 15 years we have studied 124 cases of ATLL with specific skin manifestations. Twenty-one patients (16.9%) were classified as acute, 21 (16.9%) as chronic, 26 (21.0%) as lymphoma, and 56 (45.2%) as smouldering according to Shimoyama's classification. Many patients had nodules/tumors (34.7%), erythematous plaques (22.6%), and erythematous papules (19.4%) similar to those occurring with other cutaneous T-cell lymphomas. Some patients displayed characteristic skin manifestations resembling non-neoplastic cutaneous disorders. The median survival time (MST) of all patients was 12.0 months. The MSTs of individual clinical types were: acute type, 4 months; chronic type, 14 months; lymphoma type, 7 months; and smouldering type, 16 months. In the smouldering type, cases with a deeper infiltration pattern (MST, 14 months) had a more aggressive course than those with a superficial infiltration pattern (MST, 24 months) (p < 0.05). The results indicate that smouldering type ATLL with skin manifestations may have a worse prognosis than without skin manifestations. Moreover, some cases of the smouldering type with specific skin lesions should be classified into another group with a much poorer prognosis.
Assuntos
Leucemia-Linfoma de Células T do Adulto/patologia , Dermatopatias/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Leucemia-Linfoma de Células T do Adulto/complicações , Masculino , Pessoa de Meia-Idade , Prognóstico , Dermatopatias/patologiaRESUMO
Sarcoid reactions in lymph nodes with or without metastasis from a primary malignant neoplasm are well-known. However, it is extremely rare to find these reactions associated with cutaneous solid tumors; only one such case has appeared in the literature. Here we describe a case of an 83-year-old man with cutaneous squamous cell carcinoma accompanied by sarcoid reactions and metastatic foci in the regional lymph nodes. The possibilities of systemic sarcoidosis and tuberculosis were excluded after extensive examinations specific for these diseases. Some authors regard the sarcoid reaction to be a sign of a good prognosis on the basis of studies of a few patients with solid tumors. In our case, however, the patient died of pulmonary metastasis with pleuritis carcinomatosa shortly after surgery. Systematic analysis of a sufficient number of cases should be carried out to evaluate the clinical significance of this type of reaction.